相关实验视频
Updated: Jan 13, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
895
从1976年到2016年,全球肥胖率的增加:肥胖流行病
Karsten Keller1,2, Volker H Schmitt1,3, Omar Hahad1,3
1Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
Journal of clinical medicine
|January 10, 2026
概括
全球肥胖率在1976年至2016年间显著增加,女性肥胖率更高,区域差异显著. 肥胖症的增加与全球过早死亡的增加有关.
科学领域:
- 全球健康 全球健康
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 肥胖是一个关键的全球健康问题,被世界卫生组织 (WHO) 认定为流行病.
- 了解肥胖患病率的时间趋势对于公共卫生干预至关重要.
研究的目的:
- 分析全球成年肥胖患病率的时间趋势.
- 检查肥胖患病率的区域差异及其随时间变化的情况.
主要方法:
- 利用了世卫组织全球卫生观察站和2023年全球疾病负担研究 (GBD) 的数据.
- 从1976年到2016年,分析了世卫组织各地区成年人肥胖率的粗略估计.
主要成果:
- 2016年,欧洲和美洲地区的肥胖率最高 (>20%),非洲,西太平洋和东南亚地区的肥胖率最低 (<10%).
- 在1976年至2016年期间,全球范围内观察到肥胖患病率的显著增加,美洲和欧洲显示出最大的绝对增加.
- 肥胖患病率在女性中始终高于男性,高体重指数 (BMI) 现在是导致死亡的主要危险因素,与心脏病和糖尿病有关.
结论:
- 肥胖患病率因地区而异,欧洲和美洲的患病率最高.
- 全球肥胖患病率在1976年至2016年间大幅上升.
- 肥胖是导致过早死亡的因素之一,尤其影响女性.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
233
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
233
Drug Dosing: Obese Patients
216
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
216
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
164
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
164
Stress Prevention and Stress Management Techniques IV
221
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
221
Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K

